Skip to main content
. Author manuscript; available in PMC: 2011 Mar 16.
Published in final edited form as: Stat Biopharm Res. 2009 Nov 1;1(4):348–355. doi: 10.1198/sbr.2009.0041

Figure 3.

Figure 3

PIP for ACTG A320 study assuming hazard ratio equals 0.71 and the end-of-study time was two years after the first patient was randomized.